Medical Devices – Brazil Regulatory Framework
Brazil represents the biggest market for medical devices in South America. Selling and marketing medical devices in Brazil requires several actions and compliance with legislation and standards, which can be a complex process.
Liliana Teles

Liliana Teles

Regulatory Affairs Manager

GENERAL BRAZILIAN RULES FOR MEDICAL DEVICES

According to the Brazilian National Agency of Health Surveillance (ANVISA), a medical device is “a healthcare product, such as equipment, devices, materials, articles, or systems for medical,  odontological, or laboratory use or application, intended for prevention, diagnosis, treatment, rehabilitation, or anticonception and that does not use pharmacological, immunological, or metabolic means to fulfill its main function in human beings, but can have its functions assisted by such means”.

Medical devices in Brazil must be registered in ANVISA, in accordance with the Brazilian Resolution RDC. No. 185. Manufacturers or importers of such products must submit to ANVISA all the documents required for the registration as well as for its maintenance, revalidation or cancellation. After evaluating all the documentation, ANVISA publishes its decision on the Brazilian Official Gazette (DOU).

The medical device company must be located in Brazil or it will need a licensed third-party company to be the Brazilian registration holder (BRH), which will hold the registration certificate title. Registration of medical devices is valid for 5 years and after that period it may be successively revalidated for the same period.

According to the risk they represent to consumers, patients, users or third parties involved, medical devices are classified as Class I, II, III or IV. In case of doubts in the classification, ANVISA is the one deciding about the classification. Class II devices have a shorter and simplified registration process (known as ‘Cadastro’), whereas Class III and Class IV need to go through a similar path but a little more complex and with some variants (known as ‘Registro’). Medical devices classified as Class III and IV need to be subjected to Brazilian GMP inspections, which are carried out by ANVISA. As an alternative, manufacturers can partake in the Medical Device Single Audit Program (MDSAP). MDSAP audit reports are accepted as a substitute for routine inspections and may be used for medical device registration in ANVISA.  Since May 2019 (RDC 270/2019), Class I medical devices only need a formal notification to ANVISA and do not need to submit to full ‘Cadastro’ approval (registration is not subject to technical review). This 2019 Resolution main goal was to help ANVISA to focus more on high-risk medical products. On the other hand, companies should make sure they have qualified regulatory team so they can ensure compliance with regulations.

The following medical devices are exempt from registration at ANVISA:

  • Medical devices intended for clinical research, when in compliance with legal provisions of the competent health surveillance authority on the performance of this activity, prohibiting such products to be commercialized and used for other purposes.
  • New presentations of a medical device set already registered and in intact individual packaging, provided that its label and instructions for use contain the information about the registration of the corresponding medical devices.
  • Accessories exclusively manufactured to be part of a medical device with a registration whose technical report has information on such accessories.

INMETRO CERTIFICATION

The National Institute of Metrology, Quality and Technology (INMETRO) is the government body responsible for the implementation of measurement, safety and quality standards for electrical and electronic products. This National Institute is in charge of the notification of proposed technical regulations to the World Trade Organization (WTO) and acts as the national enquiry point under the WTO Agreement on Technical Barriers to Trade (TBT). It guides the activities of accreditation, inspection, testing and certification bodies in Brazil. A broad range of products require INMETRO certification accompanied by inspection, including medical devices (electromedical, regardless of their class).

INMETRO certification (conducted in an INMETRO-certified testing laboratory) must be done prior to ANVISA approval, as it is part of the medical product’s technical documentation required for submission. A product that is certified by an INMETRO-accredited Certification Body ensures that such product is compliant with Brazilian regulations and required safety standards. INMETRO certification is valid for 5 years and may be renewed for additional 5.

Placing and marketing a medical device in Brazil market can be a tough task. With an experienced team located both in the EU and Brazil, Critical Catalyst is available to assist your company in any part of the process, making it easier and assuring compliance with the applicable regulatory requirements.

References:

  1. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC No. 185, de 22 de Outubro de 2001.
  2. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 27, de 21 de Junho de 2011.
  3. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 270, de 28 de Fevereiro de 2019.
  4. Ministério do Desenvolvimento, Indústria e Comércio Exterior, Instituto Nacional de Metrologia, Normalização e Qualidade Industrial-INMETRO – Portaria nº 350, de 06 de setembro de 2010.

further
reading

cosmetic products

Creating a “Zero Waste” Cosmetic Industry. Is it possible?

Climate changes, pollution, waste management, recycling are some of the terms we see frequently on the news and tabloids. Consumers are concerned with the planet and are demanding more innovative and sustainability ideas (“eco-friendly”). Cosmetic and personal care products have been the target of some criticism by its users. Both the cosmetic industry and governments are starting to adapt and take action with the ultimate goal of reducing plastic waste. New ingredient and packaging alternatives are being developed and more sustainable products are starting to appear on the market.

Read More »
cosmetic products

Cannabis-Derived Ingredients in Cosmetic Products

Cannabis-derived ingredients are popular and interesting compounds. There is specific EU and national legislation regarding cannabis-derived ingredients, identifying which extracts and derivatives may be used in cosmetic products. There are several aspects to consider to ensure compliance when adding these compounds to your cosmetics and personal care products.

Read More »
cosmetic products

Cosmetic Claims in the European Union

Claims are an important part of a cosmetic and represent a powerful and essential tool of marketing. It is crucial to know which claims are allowed in cosmetic products in the EU and also how can they be substantiated.

Read More »
cosmetic products

Cosmetic companies obligations under REACH Regulation

REACH is a regulation of the European Union (EU) that stands for Registration, Evaluation, Authorisation and Restriction of Chemicals. All chemical substances manufactured and market in the EU, whether used in our daily lives (e.g. clothes, cleaning products, cosmetics) or industrial processes, are regulated by REACH.

Read More »
cosmetic products

May Butylphenyl Methylpropional be used in my Cosmetic Products?

Butylphenyl Methylpropional, also known as Lilial, is a fragrance ingredient that has been used for years in several cosmetic and non-cosmetic products. Nevertheless, some concerns have been expressed regarding the use of this ingredient and its risk to consumers. The use of Butylphenyl Methylpropional shall be prohibited in cosmetic products from 1st March 2022.

Read More »
cosmetic products

RAPEX System 2020 Report

The rapid alert system (RAPEX) for dangerous non-food products enables national authorities to quickly exchange information about dangerous products. The European Union Safety Gate European RAPEX 2020 annual report was published in March this year. It lists the alerts and follow-up actions taken, per country, product category and risk notified.

Read More »
cosmetic products

Silica – a nanomaterial?

Notification of a cosmetic product containing nano-form ingredients can be complex and involves more costs for the company (cosmetic product owner). The best way to simplify the notification process is to make sure that the Silica and related ingredients used do not fall to the nanomaterial category.

Read More »
cosmetic products

Screening Assessment of Talc by Health Canada

In Canada, Talc was identified as a priority substance for assessment, so the Minister of the Environment and the Minister of Health performed a screening assessment of this compound. Regarding inhalation and perineal exposure, Talc may constitute a potential danger to human life or health.

Read More »
cosmetic products

New Revision of the SCCS Notes of Guidance

The SCCS has issued a new revision of its notes of guidance for the testing of cosmetic ingredients and their safety evaluation. This 11th revision was adopted at its plenary meeting on 30-31 March this year, and it updates the 10th revision that was published in 2018.

Read More »
cosmetic products

Is Propylparaben still considered Safe by the SCCS?

Propylparaben has been assessed several times by the European Commission’s Scientific Committee on Consumer Safety (SCCS). Last year there was a request for scientific opinion concerning the evaluation of a list of ingredients, including Propylparaben. On March, this year (2021), the SCCS issued the requested opinion on this ingredient.

Read More »
cosmetic products

China – the end of Animal Testing Requirements for Cosmetics?

Animal testing of cosmetics is already prohibited in the European Union for several years but, until now, it was mandatory to perform animal testing when making available a cosmetic product in the Chinese market. From 1st May (2021), animal testing will no longer be a requirement for ‘general’ cosmetics imported to China.

Read More »